The use of limited echocardiography in systemic arterial hypertension

C. Shub, S. G. Sheps

Research output: Contribution to journalArticle

Abstract

Left ventricular hypertrophy is an important, independent risk factor for cardiac morbidity and mortality in hypertensive patients. When properly performed and interpreted, limited echocardiography for the assessment of left ventricular hypertrophy and calculation of left ventricular mass in hypertensive patients is a relatively simple, accurate, and comparatively inexpensive, noninvasive imaging tool that is widely available. The test is used to detect increased left ventricular mass as a risk factor to help decide whether to initiate antihypertensive drug therapy in specific circumstances. Because of cost considerations, limited echocardiography is not recommended as a screening tool in all hypertensive patients. However, even though not proved by clinical trials, when used in a targeted fashion, the overall financial effect of using limited echocardiography could actually be a decrease in the total cost of lifetime care in selected hypertensive patients.

Original languageEnglish (US)
Pages (from-to)15-19
Number of pages5
JournalCardiology in Review
Volume6
Issue number1
StatePublished - 1998

Fingerprint

Echocardiography
Hypertension
Left Ventricular Hypertrophy
Costs and Cost Analysis
Antihypertensive Agents
Clinical Trials
Morbidity
Drug Therapy
Mortality

Keywords

  • Left ventricular hypertrophy
  • Left ventricular mass

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The use of limited echocardiography in systemic arterial hypertension. / Shub, C.; Sheps, S. G.

In: Cardiology in Review, Vol. 6, No. 1, 1998, p. 15-19.

Research output: Contribution to journalArticle

Shub, C. ; Sheps, S. G. / The use of limited echocardiography in systemic arterial hypertension. In: Cardiology in Review. 1998 ; Vol. 6, No. 1. pp. 15-19.
@article{f7f63e132be4415e8a1ce177e18f2a2b,
title = "The use of limited echocardiography in systemic arterial hypertension",
abstract = "Left ventricular hypertrophy is an important, independent risk factor for cardiac morbidity and mortality in hypertensive patients. When properly performed and interpreted, limited echocardiography for the assessment of left ventricular hypertrophy and calculation of left ventricular mass in hypertensive patients is a relatively simple, accurate, and comparatively inexpensive, noninvasive imaging tool that is widely available. The test is used to detect increased left ventricular mass as a risk factor to help decide whether to initiate antihypertensive drug therapy in specific circumstances. Because of cost considerations, limited echocardiography is not recommended as a screening tool in all hypertensive patients. However, even though not proved by clinical trials, when used in a targeted fashion, the overall financial effect of using limited echocardiography could actually be a decrease in the total cost of lifetime care in selected hypertensive patients.",
keywords = "Left ventricular hypertrophy, Left ventricular mass",
author = "C. Shub and Sheps, {S. G.}",
year = "1998",
language = "English (US)",
volume = "6",
pages = "15--19",
journal = "Cardiology in Review",
issn = "1061-5377",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The use of limited echocardiography in systemic arterial hypertension

AU - Shub, C.

AU - Sheps, S. G.

PY - 1998

Y1 - 1998

N2 - Left ventricular hypertrophy is an important, independent risk factor for cardiac morbidity and mortality in hypertensive patients. When properly performed and interpreted, limited echocardiography for the assessment of left ventricular hypertrophy and calculation of left ventricular mass in hypertensive patients is a relatively simple, accurate, and comparatively inexpensive, noninvasive imaging tool that is widely available. The test is used to detect increased left ventricular mass as a risk factor to help decide whether to initiate antihypertensive drug therapy in specific circumstances. Because of cost considerations, limited echocardiography is not recommended as a screening tool in all hypertensive patients. However, even though not proved by clinical trials, when used in a targeted fashion, the overall financial effect of using limited echocardiography could actually be a decrease in the total cost of lifetime care in selected hypertensive patients.

AB - Left ventricular hypertrophy is an important, independent risk factor for cardiac morbidity and mortality in hypertensive patients. When properly performed and interpreted, limited echocardiography for the assessment of left ventricular hypertrophy and calculation of left ventricular mass in hypertensive patients is a relatively simple, accurate, and comparatively inexpensive, noninvasive imaging tool that is widely available. The test is used to detect increased left ventricular mass as a risk factor to help decide whether to initiate antihypertensive drug therapy in specific circumstances. Because of cost considerations, limited echocardiography is not recommended as a screening tool in all hypertensive patients. However, even though not proved by clinical trials, when used in a targeted fashion, the overall financial effect of using limited echocardiography could actually be a decrease in the total cost of lifetime care in selected hypertensive patients.

KW - Left ventricular hypertrophy

KW - Left ventricular mass

UR - http://www.scopus.com/inward/record.url?scp=0031914103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031914103&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0031914103

VL - 6

SP - 15

EP - 19

JO - Cardiology in Review

JF - Cardiology in Review

SN - 1061-5377

IS - 1

ER -